Search Results - "Lahoutte, T."

Next-generation muscle-directed gene therapy by in silico vector design by Sarcar, S., Tulalamba, W., Rincon, M. Y., Tipanee, J., Pham, H. Q., Evens, H., Boon, D., Samara-Kuko, E., Keyaerts, M., Loperfido, M., Berardi, E., Jarmin, S., In’t Veld, P., Dickson, G., Lahoutte, T., Sampaolesi, M., De Bleser, P., VandenDriessche, T., Chuah, M. K.

“…There is an urgent need to develop the next-generation vectors for gene therapy of muscle disorders, given the relatively modest advances in clinical trials…”
Get full text

CAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab by Puttemans, J., D’Huyvetter, M., Windhorst, B., Lahoutte, T., Devoogdt, N.

Get full text

Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies by Lemaire, M, D'Huyvetter, M, Lahoutte, T, Van Valckenborgh, E, Menu, E, De Bruyne, E, Kronenberger, P, Wernery, U, Muyldermans, S, Devoogdt, N, Vanderkerken, K

Get full text

Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients by Keyaerts, M., Xavier, C., Everaert, H., Vaneycken, I., Fontaine, C., Decoster, L., Vanhoeij, M., Caveliers, V., Lahoutte, T.

Get full text

Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes by Coppens, V., Heremans, Y., Leuckx, G., Suenens, K., Jacobs-Tulleneers-Thevissen, D., Verdonck, K., Lahoutte, T., Luttun, A., Heimberg, H., De Leu, N.

“…Aims/hypothesis As current islet-transplantation protocols suffer from significant graft loss and dysfunction, strategies to sustain the long-term benefits of…”
Get full text

Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy by Aerts, A, Impens, N R E N, Gijs, M, D'Huyvetter, M, Vanmarcke, H, Ponsard, B, Lahoutte, T, Luxen, A, Baatout, S

“…Many tumors express one or more proteins that are either absent or hardly present in normal tissues, and which can be targeted by radiopharmaceuticals for…”
Get more information

Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier by Caljon, G, Caveliers, V, Lahoutte, T, Stijlemans, B, Ghassabeh, GH, Van Den Abbeele, J, Smolders, I, De Baetselier, P, Michotte, Y, Muyldermans, S, Magez, S, Clinckers, R

“…BACKGROUND AND PURPOSE Nanobodies are promising antigen‐binding moieties for molecular imaging and therapeutic purposes because of their favourable…”
Get full text

Influence of Heart Rate Reduction on Doppler Myocardial Imaging Parameters in a Small Animal Model by Weytjens, C, D'hooge, J, Droogmans, S, Van den Bergh, A, Cosyns, B, Lahoutte, T, Herijgers, P, Van Camp, G

“…Abstract In small animals studies, sick animals often have a significant reduction in heart rate while under anesthesia. The influence of heart rate reduction…”
Get full text

The role of diffusion-weighted MR imaging and ADC values in the diagnosis of gastric tumors by G Ceulemans, H Everaert, D Verdries, T Lahoutte, B Ilsen

“…In order to exclude acute pulmonary embolism, a lung perfusion scintigraphy was performed in a 53-year-old male, with a history of Fallot’s tetralogy. He had…”
Get full text

Quality control of micro-computed tomography systems by Eloot, L., Buls, N., Covens, P., Willekens, I., Lahoutte, T., de Mey, J.

“…The rapid proliferation of micro-computed tomography (micro-CT) scanners in preclinical small animal studies has created a need for a method on scanner…”
Get full text

Complete right-to-left shunt on lung perfusion SPECT results in the detection of a persistent left vena cava superior draining to the left atrium by Ceulemans, G, Everaert, H, Verdries, D, Lahoutte, T, Ilsen, B

“…In order to exclude acute pulmonary embolism, a lung perfusion scintigraphy was performed in a 53-year-old male, with a history of Fallot’s tetralogy. He had…”
Get full text

Synthesis, radiosynthesis, and in vitro characterization of [ 125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT by Mertens, J., Kersemans, V., Bauwens, M., Joos, C., Lahoutte, T., Bossuyt, A., Slegers, G.

“…[ 125I]-2-iodo-L-phenylalanine, a new radioiodinated phenylalanine analog was evaluated as a potential specific tumor tracer for SPECT. The tracer is obtained…”
Get full text

184PCAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab by Puttemans, J, D’Huyvetter, M, Windhorst, B, Lahoutte, T, Devoogdt, N

Get full text

Labelled sigma receptor ligands: can their role in neurology and oncology be extended? by Caveliers, V, Everaert, H, Lahoutte, T, Dierickx, L O, John, C S, Bossuyt, A

Get full text

In vitro characterization of the influx of 3-[ 125I]iodo-L-α-methyltyrosine and 2-[ 125I]iodo-L-tyrosine into U266 human myeloma cells: Evidence for System T transport by Lahoutte, T, Caveliers, V, Dierickx, L, Vekeman, M, Everaert, H, Mertens, J, Bossuyt, A

“…The aim of this study was to investigate the cellular uptake mechanisms responsible for the accumulation of 3-[ 125I]iodo-L-α-methyltyrosine ( 125I-3-IMT) and…”
Get full text

Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior by Dekempeneer, Yana, Bäck, Tom, Aneheim, Emma, Jensen, Holger, Puttemans, Janik, Xavier, Catarina, Keyaerts, Marleen, Palm, Stig, Albertsson, Per, Lahoutte, Tony, Caveliers, Vicky, Lindegren, Sture, D’Huyvetter, Matthias

“…The use of nanobodies (Nbs) as vehicles in targeted alpha therapy (TAT) has gained great interest because of their excellent properties. They combine high in…”
Get full text

85TiPPhase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients by Keyaerts, M, Xavier, C, Everaert, H, Vaneycken, I, Fontaine, C, Decoster, L, Vanhoeij, M, Caveliers, V, Lahoutte, T

Get full text

Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET by Dierickx, L O, Lahoutte, T, Deron, P, Caveliers, V, Vanhove, C, Everaert, H, Bossuyt, A

“…The distribution of 3-[123I]iodo-L-alpha-methyltyrosine (123I-3-IMT) in the tumour region of 21 patients with clinically suspected recurrent squamous cell head…”
Get full text

Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-α-methyl tyrosine and single photon emission tomography by DIERICKX, L O, EVERAERT, H, DERON, P, VOORDECKERS, M, LAHOUTTE, T, BOSSUYT, A

“…Early detection of residual tumour tissue offers the possibility for rapid administration of adjuvant treatment. Single photon emission tomography (SPET) with…”
Get full text

Complete right-to-left shunt on lung perfusion SPECT results in the detection of a persistent left vena cava superior draining to the left atrium by Ceulemans, G, Everaert, H, Verdries, D, Lahoutte, T, Ilsen, B

Get more information